31.07.2015 Views

WHO Drug Information Vol. 24, No. 4, 2010

WHO Drug Information Vol. 24, No. 4, 2010

WHO Drug Information Vol. 24, No. 4, 2010

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong>, <strong>Vol</strong>. <strong>24</strong>, <strong>No</strong>. 4, <strong>2010</strong> Proposed INN: List 104telotristatumtelotristattélotristattelotristat4-(2-amino-6-{(1R -1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl) phenyl])-2,2,2-trifluoroethoxy}pyrimidin-4-yl)-L-phenylalaninetryptophan hydroxylase inhibitor4-(2-amino-6-{(1R)-1-[4-chloro-2-(3-méthyl-1H-pyrazol-1-yl)phényl]-2,2,2-trifluoroéthoxy}pryrimidin-4-yl)-L-phénylalanineinhibiteur de l'hydroxylase du tryptophane4-(2-amino-6-{(1R -1-[4-cloro-2-(3-metil-1H-pirazol-1-il)fenil])-2,2,2-trifluoroetoxi}pirimidin-4-il)-L-fenilalaninainhibidor de la hidroxilasa de triptófanoC 25 H 22 ClF 3 N 6 O 3 1033805-28-5NH 2HCF 3NNOCl N N CH 3HNH 2CO 2 Htregalizumabum #tregalizumabtrégalizumabtregalizumabimmunoglobulin G1-kappa, anti-[Homo sapiens CD4 (T cell surfaceantigen T4/Leu-3, p55)], humanized monoclonal antibody;gamma1 heavy chain (1-454) [humanized VH (Homo sapiensIGHV3-15*06 (77.80%) -(IGHD)-IGHJ5*01) [8.10.15] (1-1<strong>24</strong>) -Homosapiens IGHG1*01 (125-454)], (227-218')-disulfide with kappa lightchain (1'-218') [humanized V-KAPPA (Homo sapiens IGKV4-1*01(80.20%) -IGKJ1*01) [10.3.9] (1'-111') -Homo sapiens IGKC*01(112'-218')]; (233-233":236-236")-bisdisulfide dimerimmunomodulatorimmunoglobuline G1-kappa, anti-[Homo sapiens CD4 (antigène desurface T4/Leu-3 de cellule T, p55)], anticorps monoclonalhumanisé;chaîne lourde gamma1(1-454) [VH humanisé (Homo sapiensIGHV3-15*06 (77.80%) -(IGHD)-IGHJ5*01) [8.10.15] (1-1<strong>24</strong>) -Homosapiens IGHG1*01 (125-454)], (227-218')-disulfure avec la chaînelégère kappa (1'-218') [V-KAPPA humanisé (Homo sapiens IGKV4-1*01 (80.20%) -IGKJ1*01) [10.3.9] (1'-111') -Homo sapiens IGKC*01(112'-218')]; dimère (233-233":236-236")-bisdisulfureimmunomodulateurinmunoglobulina G1-kappa, anti-[CD4 de Homo sapiens (antígenode superficie T4/Leu-3 de célula T, p55)], anticuerpo monoclonalhumanizado;cadena pesada gamma1(1-454) [VH humanizada (Homo sapiensIGHV3-15*06 (77.80%) -(IGHD)-IGHJ5*01) [8.10.15] (1-1<strong>24</strong>) -Homosapiens IGHG1*01 (125-454)], (227-218')-disulfuro con la cadenaligera kappa (1'-218') [V-KAPPA humanizada (Homo sapiens IGKV4-1*01 (80.20%) -IGKJ1*01) [10.3.9] (1'-111') -Homo sapiens IGKC*01(112'-218')]; dimero (233-233":236-236")-bisdisulfuroinmunomodulador395

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!